載入...

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Apomorphine is now recognized as the oldest antiparkinsonian drug on the market. Though still underused, it is increasingly prescribed in Europe for patients with advanced Parkinson’s disease (PD) with motor fluctuations. However, its history is far from being limited to movement disorders. This pap...

全面介紹

Na minha lista:
書目詳細資料
發表在:Drugs R D
Main Authors: Auffret, Manon, Drapier, Sophie, Vérin, Marc
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995787/
https://ncbi.nlm.nih.gov/pubmed/29546602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0230-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!